CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Public ClinicalTrials.gov record NCT07335497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Study identification
- NCT ID
- NCT07335497
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Crescent Biopharma, Inc.
- Industry
- Enrollment
- 290 participants
Conditions and interventions
Conditions
Interventions
- CR-001 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 16, 2026
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2029
- Last update posted
- May 5, 2026
2026 – 2029
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Study Site | Denver | Colorado | 80218 | Recruiting |
| Clinical Study Site | Orlando | Florida | 32827 | Recruiting |
| Clinical Study Site | Sarasota | Florida | 34236 | Recruiting |
| Clinical Study Site | Grand Rapids | Michigan | 49546 | Recruiting |
| Clinical Study Site | Columbus | Ohio | 43210 | Recruiting |
| Clinical Study Site | Nashville | Tennessee | 37203 | Recruiting |
| Clinical Study Site | Dallas | Texas | 75230 | Recruiting |
| Clinical Study Site | San Antonio | Texas | 78229 | Recruiting |
| Clinical Study Site | West Valley City | Utah | 84119 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07335497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07335497 live on ClinicalTrials.gov.